Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases.
作者信息
Li Heng, Zuo Jianping, Tang Wei
机构信息
Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuzhongzhi Road, Shanghai 201203, China.
College of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.
出版信息
Cell Mol Immunol. 2017 Sep 11;14(11):887-9. doi: 10.1038/cmi.2017.87.
Abstract
摘要
相似文献
1
Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases.
Cell Mol Immunol. 2017 Sep 11;14(11):887-9. doi: 10.1038/cmi.2017.87.
2
Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms.
Acta Pharmacol Sin. 2022 Dec;43(12):3055-3061. doi: 10.1038/s41401-022-00978-4. Epub 2022 Sep 1.
3
Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment.
Chin Med. 2021 Aug 18;16(1):80. doi: 10.1186/s13020-021-00489-0.
4
Artemisinin derivatives: a patent review (2006 - present).
Expert Opin Ther Pat. 2012 Oct;22(10):1179-203. doi: 10.1517/13543776.2012.724063. Epub 2012 Sep 13.
5
Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs.
Front Immunol. 2021 Sep 9;12:751772. doi: 10.3389/fimmu.2021.751772. eCollection 2021.
6
Therapeutic potential of artemisinin and its derivatives in managing kidney diseases.
Front Pharmacol. 2023 Feb 15;14:1097206. doi: 10.3389/fphar.2023.1097206. eCollection 2023.
7
Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.
Drugs. 1996 Dec;52(6):818-36. doi: 10.2165/00003495-199652060-00004.
8
Immune suppressive properties of artemisinin family drugs.
Pharmacol Ther. 2016 Oct;166:123-7. doi: 10.1016/j.pharmthera.2016.07.002. Epub 2016 Jul 10.
9
The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus.
Front Pharmacol. 2020 Nov 26;11:585487. doi: 10.3389/fphar.2020.585487. eCollection 2020.
10
The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases.
Med Res Rev. 2021 Nov;41(6):3023-3061. doi: 10.1002/med.21842. Epub 2021 Jul 21.
引用本文的文献
1
Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.
Trials. 2022 May 25;23(1):444. doi: 10.1186/s13063-022-06336-3.
2
Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives.
Drug Discov Today. 2022 Jul;27(7):1936-1944. doi: 10.1016/j.drudis.2022.02.007. Epub 2022 Feb 16.
3
Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.
Inflamm Res. 2019 Apr;68(4):297-310. doi: 10.1007/s00011-019-01216-0. Epub 2019 Feb 1.
4
[Artesunate attenuate chronic graft-versus-host disease by regulating Th17/Treg balance].
Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):63-68. doi: 10.3760/cma.j.issn.0253-2727.2019.01.012.
5
Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.
Acta Pharmacol Sin. 2018 Oct;39(10):1633-1644. doi: 10.1038/aps.2017.185. Epub 2018 May 31.
本文引用的文献
1
Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis.
Nat Rev Rheumatol. 2017 Feb;13(2):79-86. doi: 10.1038/nrrheum.2016.200. Epub 2016 Dec 15.
2
Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells.
Sci Rep. 2016 Nov 29;6:38115. doi: 10.1038/srep38115.
3
New insights into the immunopathogenesis of systemic lupus erythematosus.
Nat Rev Rheumatol. 2016 Nov 22;12(12):716-730. doi: 10.1038/nrrheum.2016.186.
4
Cellular and molecular regulation of innate inflammatory responses.
Cell Mol Immunol. 2016 Nov;13(6):711-721. doi: 10.1038/cmi.2016.58. Epub 2016 Oct 31.
5
Cytokines in rheumatoid arthritis - shaping the immunological landscape.
Nat Rev Rheumatol. 2016 Jan;12(1):63-8. doi: 10.1038/nrrheum.2015.171. Epub 2015 Dec 10.
6
Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
Cell Mol Immunol. 2016 May;13(3):379-90. doi: 10.1038/cmi.2015.13. Epub 2015 Mar 16.
7
Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.
Acta Pharmacol Sin. 2015 Feb;36(2):188-99. doi: 10.1038/aps.2014.134. Epub 2015 Jan 26.
8
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.
Mult Scler Int. 2014;2014:285245. doi: 10.1155/2014/285245. Epub 2014 Oct 12.
9
The immune system and kidney disease: basic concepts and clinical implications.
Nat Rev Immunol. 2013 Oct;13(10):738-53. doi: 10.1038/nri3523. Epub 2013 Sep 16.
10
Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.
PLoS One. 2013 Aug 29;8(8):e74108. doi: 10.1371/journal.pone.0074108. eCollection 2013.
Zotero 插件